These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Complete biliary obstruction due to erythromycin estolate administration in an infant. Krowchuk D, Seashore JH. Pediatrics; 1979 Dec; 64(6):956-8. PubMed ID: 514726 [No Abstract] [Full Text] [Related]
4. [Hepatocellular jaundice due to erythromycin estolate]. Zlotnick A. Harefuah; 1978 Aug; 95(3-4):127-8. PubMed ID: 700498 [No Abstract] [Full Text] [Related]
5. Erythromycin estolate and jaundice. Inman WH, Rawson NS. Br Med J (Clin Res Ed); 1983 Jun 18; 286(6382):1954-5. PubMed ID: 6407653 [Abstract] [Full Text] [Related]
6. Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases. Zafrani ES, Ishak KG, Rudzki C. Dig Dis Sci; 1979 May 18; 24(5):385-96. PubMed ID: 456225 [Abstract] [Full Text] [Related]
7. The treatment of beta hemolytic streptococcal pharyngitis. Comparison of amoxicillin, erythromycin estolate, and penicillin V. Breese BB, Disney FA, Green JL, Talpey WB. Clin Pediatr (Phila); 1977 May 18; 16(5):460-3. PubMed ID: 403044 [No Abstract] [Full Text] [Related]
8. Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate. Ginsburg CM, McCracken GH, Steinberg JB, Crow SD, Dildy BF, Lancaster K, Olsen K. Pediatr Infect Dis; 1982 May 18; 1(6):384-7. PubMed ID: 6761656 [No Abstract] [Full Text] [Related]
9. Erythromycin estolate-induced hepatitis. Ultrastructural study of liver. Gafter U, Mandel EM, Weiss S, Djaldetti M. N Y State J Med; 1979 Jan 18; 79(1):87-9. PubMed ID: 282477 [No Abstract] [Full Text] [Related]
20. FDA begins proceedings to remove erythromycin estolate from market. FDA Drug Bull; 1979 Nov 18; 9(5):26-7. PubMed ID: 510836 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]